Companies
- Companies
- Browse
Companies
Emerging pharmaceutical company developing and commercializing novel pharmaceuticals and platform technologies More
Quality Translations for Science, Industry, Government since 1957 More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Roche Protein Expression Group provides access to high-value therapeutic targets and peptides! More
Bioactive peptides for pharmaceutical and device markets More
Using its unique technology, biopharmaceutical company, Aptagen develops targeted drugs and licenses out new drugs to global pharmaceutical companies. More
Offering proprietary technologies to accelerate drug discovery of G Protein-Coupled Receptors (GPCRs), kinases, and proteases. More
Amerson Ltd. is a US based China market focused pharmaceuticals and medical products consulting firm. Our primary interest is to in-license late stage and/or US/EU approved novel healthcare products More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Jun 2006 - 1458 pages - $2,495
Dec 2010 - 28 pages - $500
Feb 2011 - 26 pages - $1,000
Mar 2011 - 20 pages - $1,000
Nov 2011 - 7 pages - $3,835
Jul 2011 - 125 pages - $3,835
Oct 2011 - 150 pages - $3,500
Jan 2011 - 49 pages - $1,000
Mar 2011 - 23 pages - $1,000
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Bacteria or virus
- Bioterrorism
- Diseases
- Hepatitis (other)
- Nosocomial infections
- Parasitic diseases
- Treatments
- Geographic location
- Canada
- USA
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us